STAGE III BLADDER CANCER

Clinical trials for STAGE III BLADDER CANCER explained in plain language.

Never miss a new study

Get alerted when new STAGE III BLADDER CANCER trials appear

Sign up with your email to follow new studies for STAGE III BLADDER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Bladder cancer drug combo falls short in early trial

Disease control Terminated

This study tested a combination of two drugs, docetaxel and lapatinib, in 15 people with advanced bladder cancer that had already been treated with chemotherapy. The goal was to see if the combination could slow cancer growth. The trial was terminated early, so results are limite…

Matched conditions: STAGE III BLADDER CANCER

Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control

Last updated Apr 29, 2026 04:27 UTC

STAGE III BLADDER CANCER

Get alerted when new STAGE III BLADDER CANCER trials appear

Bladder cancer drug combo falls short in early trial